20,000+ Doctors and continuing – How Medisage AI Spread Through India’s Medical Community

Why Doctors Stopped Trusting General AI Tools

Every doctor who has spent time with a general purpose AI chatbot has a version of the same story. The first few answers feel solid. Then something slips. A drug name appears that Indian pharmacies stopped stocking years ago. A dosage recommendation comes through that was written for a US market. A treatment suggestion sounds authoritative and turns out to be outdated in ways that would not be obvious unless the doctor already knew better. The technology is not broken. It was just never designed for this.

Building something for everyone is not the same as building something for a doctor sitting with a difficult patient at the end of a long day. Those are two entirely different problems. The tools that try to serve both end up doing neither particularly well, and in a clinical setting that gap is not just frustrating. It is dangerous.

Medisage AI did not start as something else and get redirected toward healthcare. It was designed specifically for how Indian doctors work, from the beginning. Every clinical answer is tied to peer reviewed research or validated guidelines. Drug information is matched against what is genuinely available in Indian pharmacies. A specialist at a large hospital in Mumbai and a general physician running a single handed practice somewhere in Uttar Pradesh are not working under the same conditions. The platform was built with that reality already factored in.

Reading the Numbers Honestly

Active daily users are up three times from last year. More than two thirds of people using the platform open it several times a week, not when they remember to, but as part of how they move through their working day. Over eighty percent say their confidence in handling difficult cases has genuinely improved.

Numbers from the early days of a product launch always look good because curiosity does that. These numbers are from well after the novelty wore off, from doctors who kept coming back because the tool kept being useful.

Something else worth noting is where the growth happened. A significant portion of new users came from smaller cities and towns, places where there might be one doctor serving a community that would benefit from five. In those settings, having a reliable clinical resource is not a convenience. It fills a gap that would otherwise stay empty.

How Doctors Are Actually Using It

The clinical decision support feature gets used when a case does not fit neatly into what a doctor already knows. It brings up differential diagnoses and treatment options that are grounded in current evidence and is indexed by years of case discussion MediSage has been running on its platform.

The drug intelligence engine matters in a country where availability varies so much. It checks dosing and interactions against what is actually on shelves here, which saves time and removes a real source of clinical risk.

Case based learning works because it uses real situations from practicing specialists, not theoretical scenarios from a textbook. Doctors are not reading about medicine in the abstract.

Research papers are hard to use in the middle of a busy clinic. The medical literature tool takes that research and makes it genuinely accessible at the moment a doctor needs it. Specialty modules cover cardiology, diabetology, pulmonology, oncology and others in real depth. Continuing medical education credits are built into the platform so professional development does not require blocking out separate time.

Every answer the platform gives comes with a traceable source. That is not about covering liability. It is about the basic expectation that a doctor should always be able to see the reasoning behind a recommendation before acting on it.

What This Country Actually Needs

India, with a population of 1.4 billion, lacks specialists to connect with everyone. The burden of non-communicable diseases such as diabetes, heart diseases, hypertension, cancers, etc., is growing and the distribution of medical manpower in the country hasn’t kept up with that growth. Training more doctors is part of the answer, but not a solution that helps anyone seeking care in the near term. 

The policy response has been building for years. The National Digital Health Mission, NITI Aayog’s work on AI in healthcare, the Ayushman Bharat Digital Mission, the ICMR framework for AI based clinical tools. These are not separate initiatives running in parallel. They reflect a shared understanding that reaching every patient in this country requires technology to carry part of the weight.

Medisage AI was built to contribute to that. Not as an add on, but as something designed from the start to function responsibly within that larger effort.

The One Thing That Never Changes

Everything the platform does sits on top of a single non negotiable idea. The doctor decides. The AI informs. It does not prescribe, it does not override, it does not replace judgment.

This is not language added at the end to manage expectations. It is the reason certain features were built one way and not another. The platform finds information, checks interactions, shows what the evidence supports, and then it stops. The clinical decision belongs to the doctor. It always has and the platform was built to keep it that way.

Doctors Who Have Used It

Dr. Muddhu Surendra Nehru

“I am one of the few doctors in the world who has worked more than sixteen hours a day for more than six months to build and develop on this platform and I found it extremely useful. Medisage AI is a powerful tool of education. It leverages AI to help doctors create high quality presentations and brings together the best available medical literature and evidence based suggestions. The medicinal field is changing. We are experiencing a series of paradigm shifts in the understanding and treatment of diseases. Medisage AI enables doctors to incorporate all of these advancements directly into their clinical practice. I would like to request all doctors to use this platform and develop their true potential.” 

Dr. Anil Gomber 

“Artificial intelligence must be learned and understood, especially in the field of medicine, and Medisage AI does precisely that. We have put in a great deal of work, delivered a number of lectures, and this journey with medicine has been deeply rewarding. AI is not something to be taken lightly. It is a serious instrument and Medisage AI is built with that seriousness. I wish the entire team great success and I say with full confidence that this is an initiative worth being part of.”

From the Leadership

Anurag Dhingra, Co-founder of Medisage.

“We built Medisage AI for the doctor who looks at AI to offer real assistance at critical moments and will not settle for vague responses. What I am most proud of is that MediSage AI offers a depth of clinical intelligence built using years of proprietary data on our platform. The intuitive interface we built after listening carefully to feedback from thousands of practitioners across the country, reduces friction, surfaces the right information at the right moment and feels natural inside a clinical workflow. Good AI should feel like an extension of the doctor’s own thinking. Not an interruption. Not a tool they have to manage. Just a smart friend you can rely on. That is what we have built.”

About Medisage

Medisage connects over 800,000 medical professionals across India with clinical knowledge, peer learning and AI powered decision support. Medisage AI is its flagship product, built specifically for Indian doctors, grounded in evidence and shaped around how medicine is practiced in this country.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.